Found: 107
Select item for more details and to access through your institution.
Incidence and Risk of Coronavirus Disease 2019 Hospitalization Among Unvaccinated Children.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 10, p. 1, doi. 10.1111/irv.70022
- By:
- Publication type:
- Article
The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022–August 2023.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 9, p. 1, doi. 10.1093/ofid/ofae481
- By:
- Publication type:
- Article
Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad474
- By:
- Publication type:
- Article
A Risk Score to Predict Clostridioides difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 3, p. 1, doi. 10.1093/ofid/ofab052
- By:
- Publication type:
- Article
Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 6, p. 1, doi. 10.1093/ofid/ofaa179
- By:
- Publication type:
- Article
All Older Adults Benefit From Pneumococcal Vaccinations-The Case for Evaluating Vaccine Effectiveness Using All-Cause Pneumonia.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 2, p. 141, doi. 10.1093/jpids/piaa035
- By:
- Publication type:
- Article
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 2, p. 194, doi. 10.1093/jpids/piz010
- By:
- Publication type:
- Article
Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2017, v. 6, n. 1, p. 9, doi. 10.1093/jpids/piw068
- By:
- Publication type:
- Article
Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36547-4
- By:
- Publication type:
- Article
Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination.
- Published in:
- Therapeutic Advances in Drug Safety, 2021, v. 12, p. 1, doi. 10.1177/20420986211021233
- By:
- Publication type:
- Article
Risk of COVID‐19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 3, p. 1, doi. 10.1111/irv.13269
- By:
- Publication type:
- Article
Src kinases involved in hepatitis B virus replication.
- Published in:
- EMBO Journal, 1999, v. 18, n. 18, p. 5019, doi. 10.1093/emboj/18.18.5019
- By:
- Publication type:
- Article
Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged =18 Years with Immunocompromising Conditions -- VISION Network, September 2023-February 2024.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 12, p. 271, doi. 10.15585/mmwr.mm7312a5
- By:
- Publication type:
- Article
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19--Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months--5 Years -- VISION Network, United States, July 2022--June 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 33, p. 886, doi. 10.15585/mmwr.mm7233a2
- By:
- Publication type:
- Article
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions -- VISION Network, September 2022-April 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 21, p. 579, doi. 10.15585/mmwr.mm7221a3
- By:
- Publication type:
- Article
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults -- VISION Network, Nine States, September-November 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 51/52, p. 1616, doi. 10.15585/mmwr.mm715152e1
- By:
- Publication type:
- Article
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 42, p. 1335, doi. 10.15585/mmwr.mm7142a4
- By:
- Publication type:
- Article
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated -- VISION Network, 10 States, December 2021-June 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 29, p. 931
- By:
- Publication type:
- Article
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 13, p. 495, doi. 10.15585/mmwr.mm7113e2
- By:
- Publication type:
- Article
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 7, p. 255, doi. 10.15585/mmwr.mm7107e2
- By:
- Publication type:
- Article
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance -- VISION Network, 10 States, August 2021-January 2022
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 4, p. 139, doi. 10.15585/mmwr.mm7104e3
- By:
- Publication type:
- Article
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
COVID-19 Vaccination and Non-COVID-19 Mortality Risk -- Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 43, p. 1520, doi. 10.15585/mmwr.mm7043e2
- By:
- Publication type:
- Article
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance -- Nine States, June-August 2021
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 37, p. 1291, doi. 10.15585/mmwr.mm7037e2
- By:
- Publication type:
- Article
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2020, v. 69, n. 38, p. 1355, doi. 10.15585/mmwr.mm6938e2
- By:
- Publication type:
- Article
Preterm Infants' T Cell Responses to Inactivated Poliovirus Vaccine.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 2, p. 214, doi. 10.1086/649590
- By:
- Publication type:
- Article
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2233273, doi. 10.1001/jamanetworkopen.2022.33273
- By:
- Publication type:
- Article
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. 1, doi. 10.1001/jamanetworkopen.2022.33273
- By:
- Publication type:
- Article
Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination.
- Published in:
- 2022
- By:
- Publication type:
- Opinion
Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination of Black and Latino Older Adults: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2217004, doi. 10.1001/jamanetworkopen.2022.17004
- By:
- Publication type:
- Article
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 4, p. e228879, doi. 10.1001/jamanetworkopen.2022.8879
- By:
- Publication type:
- Article
Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e221111, doi. 10.1001/jamanetworkopen.2022.1111
- By:
- Publication type:
- Article
Evaluation of Trends in Homeschooling Rates After Elimination of Nonmedical Exemptions to Childhood Immunizations in California, 2012-2020.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2146467, doi. 10.1001/jamanetworkopen.2021.46467
- By:
- Publication type:
- Article
Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 2, p. 189, doi. 10.7326/M23-2023
- By:
- Publication type:
- Article
Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 12, p. 1169, doi. 10.7326/M22-2274
- By:
- Publication type:
- Article
Assessment of Exemptions From Vaccination in California, 2015 to 2027.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Influenza Vaccination Among Pregnant Women: Self-report Compared With Vaccination Data From Electronic Health Records, 2018-2020 Influenza Seasons.
- Published in:
- Public Health Reports, 2023, v. 138, n. 3, p. 456, doi. 10.1177/00333549221099932
- By:
- Publication type:
- Article
Lack of Evidence for Vaccine‐Associated Enhanced Disease From COVID‐19 Vaccines Among Adults in the Vaccine Safety Datalink.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 8, p. 1, doi. 10.1002/pds.5863
- By:
- Publication type:
- Article
Developing algorithms for identifying major structural birth defects using automated electronic health data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 266, doi. 10.1002/pds.5177
- By:
- Publication type:
- Article
COVID-19 Booster Vaccination in Early Pregnancy and Surveillance for Spontaneous Abortion.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2314350, doi. 10.1001/jamanetworkopen.2023.14350
- By:
- Publication type:
- Article
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e232598, doi. 10.1001/jamanetworkopen.2023.2598
- By:
- Publication type:
- Article
Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229279
- By:
- Publication type:
- Article
COVID-19 Vaccine Safety Surveillance in Early Pregnancy in the United States: Design Factors Affecting the Association Between Vaccine and Spontaneous Abortion.
- Published in:
- American Journal of Epidemiology, 2023, v. 192, n. 8, p. 1386, doi. 10.1093/aje/kwad059
- By:
- Publication type:
- Article